Monitoring Telemedicine Platform in Patients With Anxiety Symptoms and Alcohol Use Disorder
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Alcohol Use Disorder
- Anxiety Disorders
- Depressive Disorder
- Design
- Observational Model: Case-ControlTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
The objective of this study is to analyze the physiological patterns of two groups of patients, one control and one with anxiety disorder and alcoholic abuse disorder using sensor data from mobile devices and wearables. This data, collected by sensors, will be compared to the data presented by three...
The objective of this study is to analyze the physiological patterns of two groups of patients, one control and one with anxiety disorder and alcoholic abuse disorder using sensor data from mobile devices and wearables. This data, collected by sensors, will be compared to the data presented by three clinical questionnaires: State-trait Anxiety Inventory (STAI), the Alcohol Use Disorders Identification Test (AUDIT), and the Beck's Depression Inventory (BDI-II) in order to determine the feasibility of using remote collected data in routine clinical practice. Furthermore, patient satisfaction with the app will be evaluated after the data collection phase. This is a unicentric, case-controlled, longitudinal, evaluational, national study with two groups, one control of healthy individuals without symptoms of anxiety or depression, and another experimental group in which participants fulfill the given selection criteria for the trial. There are a total of 60 participants split evenly between the two groups.
Tracking Information
- NCT #
- NCT03991650
- Collaborators
- Hospital Clinic of Barcelona
- European Institute of Innovation and Technology
- Investigators
- Principal Investigator: Antoni Gual, MD Director of Addictions Unit. Hospital Clínic de Barcelona Study Chair: Elsa Caballeria Clinic Foundation for Biomedical Research Study Chair: Hugo Lopez-Pelayo, MD Addictions Unit, Hospital Clínic de Barcelona Study Director: Nuria Pastor Hernandez, MSc humanITcare, FollowHealth SL Study Director: Unai Sanchez Luque, MSc humanITcare, FollowHealth SL Study Chair: Elizabeth Katayoun Khalilian humanITcare, University of Texas at Austin
Get Well Soon